Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Poon

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Angewandte Chemie (International Ed. in English)|February 21, 2007
Raftlike polyvalent inhibitors of the anthrax toxin: modulating inhibitory potency by formation of lipid microdomainsPrakash R Rai, Arundhati Saraph, Randolph Ashton, et al.
JCO Oncology Practice|May 2, 2024
Improving Access to Care, Patient Costs, and Environmental Impact Through a Community Outreach Lung Cancer Rapid Assessment ClinicBreanne Golemiec, Madison Robertson, Vincent Poon, et al.
Nature Biotechnology|April 25, 2006
Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxinsPrakash Rai, Chakradhar Padala, Vincent Poon, et al.
Archives of Virology|February 19, 2009
Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systemsJin-Yan Chen, Wan-Nan Chen, Kwok-Man Vincent Poon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Polyvalent inhibitors of anthrax toxin that target host receptorsSaleem Basha, Prakash Rai, Vincent Poon, et al.
Transportation Research Record|April 11, 2024
Impact of COVID-19 on Public Transit Accessibility and RidershipMichael Wilbur, Afiya Ayman, Amutheezan Sivagnanam, et al.
Biomacromolecules|February 10, 2011
Structure-based design of a heptavalent anthrax toxin inhibitorAmit Joshi, Sandesh Kate, Vincent Poon, et al.
Science Translational Medicine|April 30, 2014
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoproteinLiwei Jiang, Nianshuang Wang, Teng Zuo, et al.
EMBO Molecular Medicine|November 26, 2021
SPINK6 inhibits human airway serine proteases and restricts influenza virus activationDong Wang, Cun Li, Man Chun Chiu, et al.
Journal of Medicinal Chemistry|October 12, 2025
Use of P450 Enzymes for Late-Stage Functionalization in Drug DiscoveryVincent Poon, Christopher Bailey, Sandra Carvalho, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|February 21, 2007
Raftlike polyvalent inhibitors of the anthrax toxin: modulating inhibitory potency by formation of lipid microdomainsPrakash R Rai, Arundhati Saraph, Randolph Ashton, et al.
JCO Oncology Practice|May 2, 2024
Improving Access to Care, Patient Costs, and Environmental Impact Through a Community Outreach Lung Cancer Rapid Assessment ClinicBreanne Golemiec, Madison Robertson, Vincent Poon, et al.
Nature Biotechnology|April 25, 2006
Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxinsPrakash Rai, Chakradhar Padala, Vincent Poon, et al.
Archives of Virology|February 19, 2009
Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systemsJin-Yan Chen, Wan-Nan Chen, Kwok-Man Vincent Poon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Polyvalent inhibitors of anthrax toxin that target host receptorsSaleem Basha, Prakash Rai, Vincent Poon, et al.
Transportation Research Record|April 11, 2024
Impact of COVID-19 on Public Transit Accessibility and RidershipMichael Wilbur, Afiya Ayman, Amutheezan Sivagnanam, et al.
Biomacromolecules|February 10, 2011
Structure-based design of a heptavalent anthrax toxin inhibitorAmit Joshi, Sandesh Kate, Vincent Poon, et al.
Science Translational Medicine|April 30, 2014
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoproteinLiwei Jiang, Nianshuang Wang, Teng Zuo, et al.
EMBO Molecular Medicine|November 26, 2021
SPINK6 inhibits human airway serine proteases and restricts influenza virus activationDong Wang, Cun Li, Man Chun Chiu, et al.
Journal of Medicinal Chemistry|October 12, 2025
Use of P450 Enzymes for Late-Stage Functionalization in Drug DiscoveryVincent Poon, Christopher Bailey, Sandra Carvalho, et al.
Pageof 3